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Abstract
Aboriginal people experience a disproportionate burden of HIV infection among the adult
population in Canada; however, less is known regarding the prevalence and characteristics of HIV
positivity among drug-using and street-involved Aboriginal youth. We examined HIV
seroprevalence and risk factors among a cohort of 529 street-involved youth in Vancouver,
Canada. At baseline, 15 (2.8%) were HIV positive, of whom 7 (46.7%) were Aboriginal. Aboriginal
ethnicity was a significant correlate of HIV infection (odds ratio = 2.87, 95%CI: 1.02 – 8.09). Of the
HIV positive participants, 2 (28.6%) Aboriginals and 6 (75.0%) non-Aboriginals reported injection
drug use; furthermore, hepatitis C co-infection was significantly less common among Aboriginal
participants (p = 0.041). These findings suggest that factors other than injection drug use may
promote HIV transmission among street-involved Aboriginal youth, and provide further evidence
that culturally appropriate and evidence-based interventions for HIV prevention among Aboriginal
young people are urgently required.
Background
Aboriginal populations in Canada are contending with a
disproportionate burden of HIV infection [1]. Although
only 3.3% of Canadians identify as American Indian, First
Nations, Inuit, or Métis, Aboriginal people accounted for
18.8% of HIV test reports in 1998 and 27.3% in 2006
[1,2]. Within adult Aboriginal communities, injection
drug use is considered to be one of the primary modes of
HIV transmission, accounting for approximately 60% of
new HIV infections [1]. Among injection drug using pop-
ulations, Aboriginal ethnicity has also been shown to be
an independent predictor of HIV seroconversion [3,4].
Elevated rates of HIV incidence have also been observed
among young Aboriginal injection drug users [5,6].
Although the prevalence and risk factors for HIV infection
among Aboriginal injection drug users have been rela-
tively well-described, there exists little information on
HIV infection among populations of street-involved Abo-
riginal youth with heterogeneous (i.e., injection and non-
injection) drug-using characteristics and patterns. Since
HIV infections typically occur at earlier ages among Abo-
riginal people as compared to the non-Aboriginal popula-
tion [1], research examining the risk factors for HIV
infection among this age group is of particular salience to
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public health programming and policy. We undertook
this study to examine the prevalence and characteristics of
HIV positive status among a cohort of street-involved
youth in Vancouver.
Methods
The At Risk Youth Study (ARYS) is a prospective cohort of
drug-using and street-involved youth that has been
described in detail previously [7]. Snowball sampling and
extensive street-based outreach was conducted to recruit
participants into the study. Eligibility criteria included:
being between the age of 14 and 26, self-reported use of
illicit drugs other than or in addition to marijuana in the
past 30 days, and the provision of informed consent. The
study has been approved by the University of British
Columbia/Providence Health Care Research Ethics Board.
We also sought to ensure that the research protocols were
in accordance with the Canadian Institutes of Health
Research Guidelines for Health Research Involving Aboriginal
People [8].
All participants who completed a baseline survey between
September, 2005 and October, 2006 were included in this
analysis. At study entry, each participant completed an
interviewer-administered questionnaire and provided
blood samples for HIV and hepatitis C (HCV) serology.
American Indian/Aboriginal ethnicity (yes vs. no) was
defined as self-identified First Nations, Aboriginal, Inuit,
or Métis origin. Other variables that were included in this
analysis included age (<22 vs. ≥ 22), sex (female vs. male),
Downtown Eastside (DTES) residency, homelessness,
injection drug use, syringe sharing, history of incarcera-
tion, history of sex work, history of sexual abuse, ever
engaging in anal intercourse, condom use (inconsistent
vs. consistent), and for males, ever engaging in sex with
men. As described previously [9], individuals were
recorded as residents of the Downtown Eastside if they
responded "DTES" to the question, "What local neigh-
bourhoods or cities have you lived in during the past 6
months". Individuals classified as DTES residents may
include those who are homeless and sleep or spend most
of their time in the neighbourhood. To be consistent with
previous studies, syringe sharing included lending or bor-
rowing used syringes, and inconsistent condom use was
defined as not always using a condom during vaginal and
anal intercourse with all regular and casual partners
[10,11].
Pearson's chi-square test was used to determine the factors
associated with HIV positive status at baseline (Table 1).
Fisher's exact test was used when one or more of the cell
counts was less than or equal to five. Since we only
observed 15 positive diagnoses, multivariate analysis was
not conducted; however, the individual characteristics of
each HIV positive participant were aggregated and are pre-
sented in Table 2.
Findings
A total of 529 participants completed a baseline survey
and were eligible for this analysis. The median age of the
sample was 22.0 (interquartile range: 19.9 – 23.9), 159
(30.1%) were female, 404 (76.4%) had been homeless in
the past six months, and 221 (41.8%) reported ever inject-
ing. In total, 127 (24.0%) participants self-identified as
Aboriginal, American Indian, First Nations, Inuit, or
Métis.
Of the entire sample, 15 (2.8%) tested positive for HIV, of
whom 7 (46.7%) were of Aboriginal ethnicity. As shown
in Table 1, Aboriginal ethnicity was associated with HIV
infection (odds ratio [OR] = 2.87, 95%CI: 1.02 – 8.09), as
was injection drug use (OR = 2.75, 95%CI: 0.98 – 7.73)
and sex trade work (OR = 4.35, 95%CI: 1.54 – 12.26).
Younger participants were less likely to be infected with
HIV (OR = 0.14, 95%CI: 0.03 – 0.65).
Among the HIV positive individuals (Table 2), only 2
(28.6%) Aboriginal participants reported injecting drugs
and none reported sharing syringes. HIV-infected Aborig-
inal youth were significantly less likely to be co-infected
with HCV (Fisher's exact test p-value = 0.041).
Discussion
Among a community-based sample of street-involved
youth, Aboriginal participants were more than two and a
half times more likely to be infected with HIV. The preva-
lence of HIV among Aboriginal youth in this sample was
5.5%, a proportion similar to that reported in a recent
study of at-risk Aboriginal youth in two cities in British
Columbia [12]. The prevalence of HIV among Aboriginal
youth in this setting is also substantially higher than those
that have been observed among street youth populations
in Montréal (1.9%) and Toronto (2.2%) [13,14]. Further-
more, the fact that HIV-infected Aboriginal youth were
less likely to report injection drug use and be co-infected
with HCV suggests that unsafe sexual activity, sex work,
and other unmeasured antecedent factors may be respon-
sible for a significant proportion of infections. These find-
ings are concerning and suggest that immediate and
culturally appropriate policy and programmatic remedies
are required to prevent further infections among Aborigi-
nal youth and to provide increased resources to those
individuals who are already infected.
Other factors that were associated with HIV positivity in
bivariate analysis are similar to other studies of HIV infec-
tion among street-involved youth in Canada. For exam-
ple, older age, history of injection drug use, and sex work
were also all significant correlates of HIV infection amongHarm Reduction Journal 2008, 5:35 http://www.harmreductionjournal.com/content/5/1/35
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a cohort of street-involved youth in Montreal [14]. Of par-
ticular relevance to our setting is the high prevalence of
incarceration observed among both HIV positive and neg-
ative participants – in fact, all seven HIV positive Aborigi-
nal individuals also reported a history of incarceration.
Given that incarceration has been associated with both
HIV risk behaviours [15] and HIV incidence [16] in Van-
couver, interventions to reduce street youths' exposure to
correctional environments and the HIV-related harms
associated with them are in urgent need of evaluation. Of
further concern is that over half of HIV-infected Aborigi-
nal participants reported experiencing sexual abuse, a
finding which supports a recent study showing strong
associations between sexual abuse and HIV risk behav-
iours among this population [17]. These results suggest
that programs which aim to support HIV positive Aborig-
inal young people should recognize and address the last-
ing effects of historical trauma and cultural assimilation
stemming from the Canadian residential school system
on current levels of sexual abuse, substance use, and other
HIV-related vulnerabilities.
Recently, the federal government of Canada announced
that funding to community and regional HIV programs
would be redirected towards the Canadian HIV Vaccine
Initiative [18,19]. Although research funding for HIV vac-
Table 1: Factors associated with HIV seropositive status among a cohort of homeless and street-involved youth (n = 529)
Characteristic HIV Positive
n (%)
n = 15
HIV Negative
n (%)
n = 514
Odds Ratio
(95% CI)
p-value
Age
< 22 2 (13.3) 265 (51.6) 0.14 (0.03 – 0.65) 0.003
≥ 22 13 (86.7) 249 (48.4)
Sex
Female 5 (33.3) 153 (29.8) 1.18 (0.40 – 3.51) 0.778
Male 10 (66.7) 361 (70.2)
Aboriginal Ethnicity
Yes 7 (46.7) 120 (23.3) 2.87 (1.02 – 8.09) 0.037
No 8 (53.3) 394 (76.7)
DTES Residency†
Yes 4 (26.7) 139 (27.0) 0.98 (0.31 – 3.13) 1.000
No 11 (73.3) 375 (73.0)
Homeless†
Yes 11 (73.3) 393 (76.5) 0.85 (0.26 – 2.71) 0.761
No 4 (26.7) 121 (23.5)
Injection Drug Use†
Yes 8 (53.3) 151 (29.4) 2.75 (0.98 – 7.73) 0.046
No 7 (46.7) 363 (70.6)
Syringe Sharing†
Yes 3 (20.0) 45 (8.8) 2.59 (0.70 – 9.56) 0.148
No 12 (80.0) 467 (91.2)
Incarceration‡
Yes 11 (73.3) 382 (74.3) 0.95 (0.30 – 3.04) 1.000
No 4 (26.7) 132 (25.7)
Sex Work‡
Yes 8 (53.3) 107 (20.8) 4.35 (1.54 – 12.26) 0.003
No 7 (46.7) 407 (79.2)
Sexual Abuse‡
Yes 6 (42.9) 132 (26.0) 2.13 (0.73 – 6.23) 0.271
No 8 (57.1) 375 (74.0)
MSM‡
Yes 2 (13.3) 33 (6.4) 2.24 (0.49 – 10.36) 0.261
No 13 (86.7) 481 (93.6)
Anal Intercourse‡
Yes 5 (33.3) 149 (29.0) 1.22 (0.41 – 3.64) 0.774
No 10 (66.7) 365 (71.0)
Condom Use* †
Inconsistent 4 (57.1) 284 (69.6) 0.58 (0.13 – 2.65) 0.442
Consistent 3 (42.9) 124 (30.4)
Note: † – refers to activities in the past 6 months; ‡ – refers to lifetime history; * – among sexually active participantsHarm Reduction Journal 2008, 5:35 http://www.harmreductionjournal.com/content/5/1/35
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cines is undoubtedly integral to long-term HIV strategies,
the observed prevalence of HIV among Aboriginal youth
observed in this and other studies supports statements
made by the Assembly of First Nations that, relative to the
size of the epidemic, HIV programs for Aboriginal pro-
grams are chronically under-funded and are in urgent
need of further investment [20]. The Canadian Aboriginal
AIDS Network has also argued that a serious lack of youth-
specific HIV prevention programmes for Aboriginal youth
exists across the country, and as such a national strategy
on Aboriginal youth HIV/AIDS prevention is required
[21]. Given these concerns, research and interventions
that seek to identify effective strategies for addressing HIV
infection and related vulnerabilities among Aboriginal
young people should be a public health priority.
Our study is limited by its nonrandom sampling method-
ology that precludes generalization to the larger street-
involved population in British Columbia. However, the
sociodemographic characteristics of our sample are simi-
lar to those observed among other street youth studies in
this setting [22,23]. Secondly, stigmatized behaviours
such as injection drug use and syringe sharing may be
underreported, particularly as the reliability and validity
of self-report among samples of Aboriginal youth has
been questioned by some authors [24]. However, a review
of studies assessing the reliability and validity of self-
reported drug use and HIV risk behaviours among injec-
tion drug users concluded that these measures are suffi-
ciently valid [25]. It is also important to note that the
prevalence of injection drug use and related behaviours
reported in our study are similar to those from a recently
published analysis of risk behaviours among Aboriginal
youth who use drugs in Vancouver [12]. Even if socially
desirable reporting were present in the data, we have no
reason to believe that Aboriginal and non-Aboriginal par-
ticipants would differ with respect to the likelihood of the
underreporting of certain behaviours. Furthermore, it is
noteworthy that biological evidence (i.e., hepatitis C
serostatus) supports the self-reported data suggesting a
higher proportion of sexually acquired HIV among Abo-
riginal participants. Finally, although we recognize that
HIV vulnerability among Aboriginal populations is pro-
duced through a complex interplay of social, structural,
and historical factors such as poverty, cultural oppression,
and the multigenerational effects of the residential school
system [6], we were unable to measure and characterize
many of these effects.
In summary, we observed an alarmingly high prevalence
of HIV infection among street-involved Aboriginal youth.
Our findings demonstrate that urgent and culturally
appropriate action is required to address the pervasive
inequities that perpetuate marginalization and height-
ened vulnerability to HIV among Aboriginal young peo-
ple in Canada.
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Table 2: Characteristics of HIV positive homeless and street-
involved youth (n = 15).
Characteristic Aboriginal
n (%)
n = 7
Non-Aboriginal
n (%)
n = 8
Age < 22 1 (14.3) 1 (12.5)
Female 3 (42.9) 2 (25.0)
DTES Residency† 3 (42.9) 1 (12.5)
Homeless† 5 (71.4) 6 (75.0)
Injected Drugs† 2 (28.6) 6 (75.0)
Shared Syringes† 0 (0.0) 3 (37.5)
Incarceration‡ 7 (100.0) 5 (62.5)
Sex Work‡ 4 (57.1) 4 (50.0)
Sexual Abuse‡ 4 (57.1) 2 (25.0)
MSM‡ 2 (28.6) 0 (0.0)
Anal Intercourse‡ 2 (28.6) 3 (37.5)
Inconsistent Condom Use† 2 (28.6) 2 (25.0)
Hepatitis C Infection 1 (14.3) 6 (75.0)
Note: † – refers to activities in the past 6 months; ‡ – refers to 
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